OMGA: Omega Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 129.61
Enterprise Value ($M) 80.06
Book Value ($M) 58.02
Book Value / Share 1.05
Price / Book 2.23
NCAV ($M) -77.91
NCAV / Share -1.41
Price / NCAV -1.66

Profitability (mra)
Return on Invested Capital (ROIC) -0.52
Return on Assets (ROA) -0.62
Return on Equity (ROE) -0.79

Liquidity (mrq)
Quick Ratio 2.55
Current Ratio 2.55

Balance Sheet (mrq) ($M)
Current Assets 68.44
Assets 204.37
Liabilities 146.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.09
Operating Income -100.26
Net Income -97.43

Cash Flow Statement (mra) ($M)
Cash From Operations -91.51
Cash from Investing 47.52
Cash from Financing 41.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Fmr Llc 10.68 11.39
02-09 13G/A HarbourVest Partners L.P. 6.40 32.68

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 47,332 81,831 57.84
2024-04-25 67,723 65,919 102.74
2024-04-24 86,837 51,173 169.69
2024-04-23 61,442 117,901 52.11
2024-04-22 37,004 65,218 56.74

(click for more detail)

Similar Companies
NXTC – NextCure, Inc. OGI – Organigram Holdings Inc.
OLMA – Olema Pharmaceuticals, Inc. OPK – OPKO Health, Inc.
OPTN – OptiNose, Inc.


Financial data and stock pages provided by
Fintel.io